In vitro phototoxicity of ultradeformable liposomes containing chloroaluminum phthalocyanine against New World Leishmania species

Journal of Photochemistry and Photobiology B: Biology

Volumn 117, Issue , 2012, Pages 157-163

  Hernández, Indira Paola ^a   Montanari, Jorge ^b   Valdivieso, Wilfredo ^a   Morilla, Maria Jose ^b   Romero, Eder Lilia ^b   Escobar, Patricia ^a  

^a UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

^b UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

Author keywords

Chloroaluminum phthalocyanine; Leishmania chagasi; Leishmania panamensis; Photodynamic therapy; Ultradeformable liposomes

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMPHOTERICIN B; CHLOROALUMINUM PHTHALOCYANINE; LIPOSOME; ULTRADEFORMABLE LIPOSOME; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENCAPSULATION; FLUORESCENCE MICROSCOPY; IC 50; IN VITRO STUDY; INTERNALIZATION; LEISHMANIA CHAGASI; LEISHMANIA PANAMENSIS; MAMMAL CELL; NONHUMAN; PHOTOACTIVATION; PHOTOTOXICITY; PRIORITY JOURNAL; PROMASTIGOTE; SKIN LEISHMANIASIS;

BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; HUMANS; INDOLES; LEISHMANIA; LIPOSOMES; MITOCHONDRIA; ORGANOMETALLIC COMPOUNDS; PHOSPHOLIPIDS; PHOTOSENSITIZING AGENTS; SPECIES SPECIFICITY;

LEISHMANIA DONOVANI CHAGASI; LEISHMANIA PANAMENSIS; MAMMALIA;

EID: 84868262624     PISSN: 10111344     EISSN: 18732682     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2012.09.018     Document Type: Article

References (53)

1. P. Desjeux Leishmaniasis: current situation and new perspectives Comp. Immunol. Microbiol. Infect. Dis. 27 2004 305 318
2. R. Reithinger, J.C. Dujardin, H. Louzir, C. Pirmez, B. Alexander, and S. Brooker Cutaneous leishmaniasis Lancet Infec. Dis. 7 2007 581 596
3. S.L. Croft, and P. Olliaro Leishmaniasis chemotherapy-challenges and opportunities Eur. J. Clin. Microbiol. Infect. Dis. 17 2011 1478 1483
4. M. Ameen Cutaneous and mucocutaneous leishmaniasis: emerging therapies and progress in disease management Expert Opin. Pharmacother. 11 2010 557 569
5. S. Sundar, J. Chakravarty, V.K. Rai, N. Agrawal, S.P. Singh, V. Chauhan, and H.W. Murray Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions Clin. Infec. Dis. 45 2007 556 561
6. H.W. Murray Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India Future Microbiol. 5 2010 2010 1301 1303
7. A. Ben Salah, P.A. Buffet, G. Morizot, N. Ben Massoud, A. Zaatour, N. Ben Alaya, N.B. Haj Hamida, Z. El Ahmadi, M.T. Downs, P.L. Smith, K. Dellagi, and M. Grogl WR279, 396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study PLoSNegl. Trop. Dis. 3 2009 e432
8. G. Wortmann, M. Zapor, R. Ressner, S. Fraser, J. Hartzell, J. Pierson, A. Weintrob, and A. Magill Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis Am. J. Trop. Med. Hyg. 83 2010 1028 1033
9. J. Alvar, S. Croft, and P. Olliaro Chemotherapy in the treatment and control of leishmaniasis Adv. Parasitol. 61 2006 223 274
10. T. Garnier, and S.L. Croft Topical treatment for cutaneous leishmaniasis Curr. Opin. Investig. Drugs 3 2002 538 544
11. J. Soto, B.A. Arana, J. Toledo, N. Rizzo, J.C. Vega, A. Diaz, M. Luz, P. Gutierrez, M. Arboleda, J.D. Berman, K. Junge, J. Engel, and H. Sindermann Miltefosine for new world cutaneous leishmaniasis Clin. Infec. Dis. 38 2004 1266 1272
12. S.M. Fien, and A.R. Oseroff Photodynamic therapy for non-melanoma skin cancer J. Natl. Compr. Cancer Network 5 2007 531 540
13. C.A. Kendall, and C.A. Morton Photodynamic therapy for the treatment of skin disease Tech. Canc. Res. Treat. 2 2003 283 288
14. A. Asilian, and M. Davami Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial Clin. Exp. Dermatol. 31 2006 634 637
15. C.D. Enk, K. Gardlo, M. Hochberg, A. Ingber, and T. Ruzicka Cutaneous leishmaniasis Hautarzt 54 2003 506 512
16. K. Gardlo, Z. Horska, C.D. Enk, L. Rauch, M. Megahed, T. Ruzicka, and C. Fritsch Treatment of cutaneous leishmaniasis by photodynamic therapy J. Am. Acad. Dermatol. 48 2003 893 896
17. O.E. Akilov, S. Kosaka, K. O'Riordan, and T. Hasan Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells Exp. Dermatol. 16 2007 651 660
18. O.E. Akilov, S. Kosaka, K. O'Riordan, and T. Hasan Photodynamic therapy for cutaneous leishmaniasis: the effectiveness of topical phenothiaziniums in parasite eradication and Th1 immune response stimulation Photochem. Photobiol. Sci. 6 2007 1067 1075
19. O.E. Akilov, S. Kosaka, K. O'Riordan, X. Song, M. Sherwood, T.J. Flotte, J.W. Foley, and T. Hasan The role of photosensitizer molecular charge and structure on the efficacy of photodynamic therapy against Leishmania parasites Chem. Biol. 13 2006 839 847
20. S. Dutta, D. Ray, B.K. Kolli, and K.P. Chang Photodynamic sensitization of Leishmania amazonensis in both extracellular and intracellular stages with aluminum phthalocyanine chloride for photolysis in vitro Antimicrob. Agents Chemother. 49 2005 4474 4484
21. P. Escobar, I.P. Hernandez, C.M. Rueda, F. Martinez, and E. Paez Photodynamic activity of aluminium (III) and zinc (II) phthalocyanines in Leishmania promastigotes Biomedica 26 1 2006 49 56
22. J.B. Morgenthaler, S.J. Peters, D.L. Cedeno, M.H. Constantino, K.A. Edwards, E.M. Kamowski, J.C. Passini, B.E. Butkus, A.M. Young, T.D. Lash, and M.A. Jones Carbaporphyrinketals as potential agents for a new photodynamic therapy treatment of leishmaniasis Bioorg. Med. Chem. 16 2008 7033 7038
23. V.M. Taylor, D.L. Cedeño, D.L. Muñoz, M.A. Jones, T.D. Lash, A.M. Young, M.H. Constantino, N. Esposito, I.D. Vélez, and S.M. Robledo In vitro and in vivo studies of the utility of dimethyl and diethyl carbaporphyrinketals in treatment of cutaneous leishmaniasis Antimicrob. Agents. Chemother. 55 2011 4755 4764
24. W.S. Chan, N. Brasseur, C. La Madeleine, R. Ouellet, and J.E. van Lier Efficacy and mechanism of aluminium phthalocyanine and its sulphonated derivatives mediated photodynamic therapy on murine tumours Eur. J. Cancer 33 1997 1855 1859
25. S.K. Pushpan, S. Venkatraman, V.G. Anand, J. Sankar, D. Parmeswaran, S. Ganesan, and T.K. Chandrashekar Porphyrins in photodynamic therapy - a search for ideal photosensitizers Curr. Med. Chem. Anticancer Agents 2 2002 187 207
26. R.R. New, M.L. Chance, S.C. Thomas, and W. Peters Antileishmanial activity of antimonials entrapped in liposomes Nature 272 1978 55 56
27. S. Pal, R. Ravindran, and N. Ali Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmaniadonovani infection in BALB/c Mice Antimicrob. Agents Chemother. 48 2004 3591 3593
28. A. Papagiannaros, C. Bories, C. Demetzos, and P.M. Loiseau Antileishmanial and trypanocidal activities of new miltefosine liposomal formulations Biomed. Pharmacother. 59 2005 545 550
29. G. Cevc, and G. Blume Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force Biochim. Biophys. Acta 1104 1992 226 232
30. G. Cevc, and D. Gebauer Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier Biophys. J. 84 2003 1010 1024
31. J. Montanari, C. Maidana, M.I. Esteva, C. Salomon, M.J. Morilla, and E.L. Romero Sunlight triggered photodynamic ultradeformable liposomes against Leishmania braziliensis are also leishmanicidal in the dark J. Control. Release. 147 2010 368 376
32. D.D. Verma, S. Verma, G. Blume, and A. Fahr Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study Eur. J. Pharm. Biopharm. 55 2003 271 277
33. J. Montanari, A.P. Perez, F. Di Salvo, V. Diz, R. Barnadas, L. Dicelio, F. Doctorovich, M.J. Morilla, and E.L. Romero Photodynamic ultradeformable liposomes: design and characterization Int. J. Pharmaceut. 330 2007 183 194
34. G. Cevc Biophysical view of the role of interfaces in biomolecular recognition Biophys. Chem. 55 1995 43 53
35. G.R. Barlett Phosphorous assay in column chromatography J. Biol. Chem. 234 1959 466 468
36. P. Escobar, S. Milena Leal, L.V. Herrera, J.R. Martinez, and E. Stashenko Chemical composition and antiprotozoal activities of Colombian Lippia spp essential oils and their major components Mem. Inst. Osw. Cruz. 105 2010 184 190
37. M. Owais, and C.M. Gupta Targeted drug delivery to macrophages in parasitic infections Curr. Drug Deliv. 4 2005 311 318
38. C. Kelly, C. Jefferies, and S.A. Cryan Targeted liposomal drug delivery to monocytes and macrophages J. Drug Deliv. 2011 10.1155/2011/727241
39. G. Cevc Lipid vesicles and other colloids as drug carriers on the skin Adv. Drug Deliv. Reviews 56 2004 675 711
40. P. Schäfer, C. Bewick-Sonntag, M.G. Capri, and E. Berardesca Physiological changes in skin barrier function in relation to occlusion level, exposure time and climatic conditions Skin Pharmacol. Appl. Skin Physiol. 15 2002 7 19
41. M. Schaller, and H.C. Korting Interaction of liposomes with human skin: the role of the stratum corneum Adv. Drug Deliv. Reviews 18 1996 303 309
42. V. Yardley, and S.L. Croft Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis Antimicrob. Agents Chemother. 41 1997 752 756
43. C. Fabris, G. Valduga, G. Miotto, L. Borsetto, G. Jori, S. Garbisa, and E. Reddi Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis Cancer Res. 61 2001 7495 7500
44. E. Alexandratou, D. Yova, and S. Loukas A confocal microscopy study of the very early cellular response to oxidative stress induced by zinc phthalocyanine sensitization Free Radic. Biol. Med. 39 2005 1119 1127
45. R. Chen, Z. Huang, G. Chen, Y. Li, X. Chen, J. Chen, and H. Zeng Kinetics and subcellular localization of 5-ALA-induced PpIX in DHL cells via two-photon excitation fluorescence microscopy Int. J. Oncol. 32 2008 861 867
46. H. Li, T.J. Jensen, F.R. Fronczek, and M.G. Vicente Syntheses and properties of a series of cationic water-soluble phthalocyanines J. Med. Chem. 51 2008 502 511
47. G.M. Malham, R.J. Thomsen, G.J. Finlay, and B.C. Baguley Subcellular distribution and photocytotoxicity of aluminium phthalocyanines and haematoporphyrin derivative in cultured human meningioma cells Br. J. Neurosurg. 10 1996 51 57
48. J. Usuda, S.M. Chiu, E.S. Murphy, M. Lam, A.L. Nieminen, and N.L. Oleinick Domain-dependent photodamage to Bcl-2. A membrane anchorage region is needed to form the target of phthalocyanine photosensitization J. Biol. Chem. 278 2003 2021 2029
49. D. Kessel, and Y. Luo Mitochondrial photodamage and PDT-induced apoptosis J. Photochem. Photobiol. B 42 1998 89 95
50. H.R. Kim, Y. Luo, G. Li, and D. Kessel Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection Cancer Res. 59 1999 3429 3432
51. F. Frézard, and C. Demicheli New delivery strategies for the old pentavalent antimonial drugs Expert. Opin. Drug. Deliv. 7 2010 1343 1358
52. C.R. Alving, E.A. Steck, W.L. Hanson, P.S. Loizeaux, W.L. Chapman Jr., and V.B. Waits Improved therapy of experimental leishmaniasis by use of a liposome-encapsulated antimonial drug Life Sci. 22 1978 1021 1026
53. P.Y. Guru, A.K. Agrawal, U.K. Singha, A. Singhal, and C.M. Gupta Drug targeting in Leishmaniadonovani infections using tuftsin-bearing liposomes as drug vehicles FEBS Lett. 245 1989 204 208